BILL vs LYEL · rev $1.65B vs rev $6.0K
Bill Com Holdings Inc (BILL) versus Lyell Immunopharma Inc (LYEL) — a side-by-side from cached financials, not a winner call.
Bill Com Holdings Inc (BILL) is a software - application company listed on US.
Lyell Immunopharma Inc (LYEL) is a biotechnology company listed on US.
Latest reported BILL revenue for 2026-06-30 was $1.65B. Net income was -$11.2M. Revenue was up 13.0% from 2025-06-30 to 2026-06-30. BILL currently screens at market cap $4.78B.
Latest reported LYEL revenue for 2026-06-30 was $6.0K. Net income was -$68.9M. LYEL currently screens at market cap $143.5M.
BILL currently screens at market cap $4.78B. LYEL currently screens at market cap $143.5M.
Not investment advice. Open the BILL and LYEL stock pages for the full models.
Not investment advice.